Potassium%252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an electrolyte replacement agent used to treat or prevent hypokalemia. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing Dosage varies significantly based on serum potassium levels and clinical status. Local protocols or physician orders should be followed. * **Prevention of hypokalemia:** Typically 20 mEq (10 mmol) per day. * **Treatment of hypokalemia:** * Mild hypokalemia (serum K+ 3.0-3.4 mEq/L): 40-80 mEq (20-40 mmol) per day in divided doses. * Moderate hypokalemia (serum K+ 2.5-2.9 mEq/L): 60-100 mEq (30-50 mmol) per day in divided doses. * Severe hypokalemia (serum K+ < 2.5 mEq/L): May require intravenous administration, with doses up to 20 mEq/hour, not to exceed 400 mEq (200 mmol) in 24 hours. **Maximum infusion rate for IV KCL is typically 10-20 mEq/hour to prevent cardiac arrhythmias and phlebitis. Higher rates should only be used in critical situations with continuous cardiac monitoring.** * Oral doses are often divided into 2-4 administrations. Maximum single oral dose typically 20 mEq (10 mmol) to reduce GI upset. ## Pediatric Dosing Dosage varies by age, weight, and serum potassium levels. Local protocols or physician orders should be followed. * **Maintenance:** 1-2 mEq/kg/day, not to exceed 100 mEq (50 mmol)/day. * **Correction:** Higher doses may be required based on potassium deficit. Intravenous administration rates should generally not exceed 0.5 mEq/kg/hour, not to exceed 10-20 mEq/hour, with continuous cardiac monitoring. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Dosage must be reduced. Patients with severe renal impairment may not be able to excrete potassium, increasing the risk of hyperkalemia. * **Adrenal Insufficiency:** May require lower doses. ## Contraindications * Hyperkalemia. * Conditions which may predispose to hyperkalemia (e.g., anuria, oliguria, severe renal impairment, Addison's disease). * Certain gastrointestinal obstructions or paralytic ileus. ## Adverse Effects * **Common:** Gastrointestinal upset (nausea, vomiting, abdominal pain, diarrhea), especially with oral administration. * **Serious:** Hyperkalemia (symptoms include muscle weakness, fatigue, paresthesias, cardiac arrhythmias, cardiac arrest), which can be life-threatening. Esophageal or gastric ulceration/perforation with oral forms, especially if not taken with sufficient fluid or in patients with delayed gastric emptying. Phlebitis with IV administration. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors, Angiotensin II receptor blockers (ARBs):** Increased risk of hyperkalemia. * **NSAIDs:** May reduce potassium excretion, increasing risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase digoxin toxicity. Hypokalemia can decrease digoxin efficacy and increase risk of arrhythmias. ## Monitoring * **Serum potassium levels:** Monitor frequently, especially during initiation, dose changes, or in patients with renal impairment. * **Electrocardiogram (ECG):** To assess for signs of hyperkalemia, particularly with rapid IV administration or in at-risk patients. * **Renal function:** Monitor creatinine and BUN. * **Signs and symptoms of hyperkalemia.** ## Clinical Pearls * Oral potassium chloride tablets should be taken with meals and a full glass of water to minimize gastrointestinal irritation. * Liquid formulations may be preferred for patients with difficulty swallowing or to reduce GI side effects. * Intravenous potassium chloride must be diluted and infused slowly with cardiac monitoring, especially at higher infusion rates. Never administer as an IV push. * The risk of hyperkalemia is significantly increased in patients with renal impairment. *** *Disclaimer: This information is intended for clinical pharmacists and healthcare professionals. It is essential to consult the most current prescribing information and relevant guidelines for definitive patient care decisions. Dosing and indications may vary based on specific product labeling, patient factors, and local institutional protocols.*